Peptides by condition · Hormones and sexual health

Peptides studied for low testosterone (hypogonadism)

Checked against our study pages and the FDA labelsPublished by PepVault

Our library holds 15 study pages on low testosterone (hypogonadism): 14 in people (9 of them meta-analyses or randomized trials), and 1 in animals. They studied 4 compounds, with this many study pages each: Enclomiphene 6, HCG 4, Clomiphene 4 and FOXO4-DRI 1.

What the research on low testosterone (hypogonadism) looks like

Hypogonadism means the testes make too little testosterone. In the secondary form the testes are able to, but the brain sends too weak a signal through the hormone LH. The compounds studied here aim at that signal, so the body makes more of its own testosterone instead of having it replaced from outside, and some of them are pills rather than peptides. Enclomiphene, for one, is one of the two mirror-image forms that make up clomiphene, an older fertility pill.

These trials measure morning testosterone, LH and FSH in the blood, and often sperm count, because testosterone given from outside can shut sperm production down. A blood level back in the normal range is the usual target.

Check whether a trial compared the drug with placebo or with testosterone gel, and how long it lasted. A rise on a blood test is the measured result; how men felt was tested far less often. A study in aged mice, whose testes themselves wear out, describes a different problem from the weak brain signal of the secondary form.

Our study pages on low testosterone (hypogonadism) by design: Trials in people 9, Other in people 5, Animals 1, Cells 0, of 15.Trials in people9Other in people5Animals1Cells0
How many of the 15 study pages on this condition reach each design, strongest at the top: meta-analyses and randomized trials in people, other studies in people, animals, cells.
A smiling man in an olive shirt leaning on a porch railing with his phone

PepVault for iPhone

Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The 15 studies, by compound

Grouped by the compound each study is filed under, and within each, strongest design first. Each line gives the design, who was studied, how many and the year, before the finding.

  1. Enclomiphene

    6 in people

    For low testosterone (hypogonadism), 6 of our study pages are filed under Enclomiphene: 1 meta-analysis, 4 randomized trials and 1 observational study in people. The largest in people enrolled 66 people and was published in 2024. They were published from 2013 to 2025, in Arch Endocrinol Metab, J Sex Med, BJU Int, Fertil Steril and Transl Androl Urol.

    Enclomiphene has no FDA-approved product of its own: Drugs@FDA lists no application for it. It is one of the two isomers in clomiphene citrate, which is approved (Clomid); Clomid’s label calls clomiphene citrate “a mixture of two geometric isomers [cis (zuclomiphene) and trans (enclomiphene)]”.

  2. HCG

    4 in people

    For low testosterone (hypogonadism), 4 of our study pages are filed under HCG: 2 randomized trials and 2 observational studies in people. The largest in people enrolled 6,999 people and was published in 2026. They were published from 2002 to 2026, in Eur J Endocrinol, J Clin Endocrinol Metab, World J Mens Health and J Urol.

    FDA-approved, with a use tied to low testosterone (hypogonadism) on its label: Chorionic Gonadotropin (injection) for undescended testicles in boys, low testosterone from a pituitary cause in men, and triggering ovulation in women after fertility treatment (its label says it is not for weight loss); Novarel (injection) for undescended testicles in boys, low testosterone from a pituitary cause in men, and triggering ovulation in women after fertility treatment (its label says it is not for weight loss); Pregnyl (injection) for undescended testicles in boys, low testosterone from a pituitary cause in men, and triggering ovulation in women after fertility treatment (its label says it is not for weight loss). Under Ovidrel it is approved for other uses.

  3. Clomiphene

    4 in people

    For low testosterone (hypogonadism), 4 of our study pages are filed under Clomiphene: 2 randomized trials, 1 clinical trial and 1 observational study in people. The largest in people enrolled 46 people and was published in 2012. They were published from 2012 to 2021, in Horm Metab Res, Int J Obes (Lond), J Clin Endocrinol Metab and BJU Int.

    FDA-approved for other uses, not for low testosterone (hypogonadism): Clomid (tablet) for ovulation problems in women who want to become pregnant.

  4. FOXO4-DRI

    1 in animals

    For low testosterone (hypogonadism), 1 of our study pages is filed under FOXO4-DRI: 1 animal study (mice). It was published in 2020, in Aging (Albany NY).

    FOXO4-DRI has no FDA-approved product: Drugs@FDA lists no application for it.

Side by side

For the 4 compounds on this page: studies in people, studies in animals or cells, the size of the largest study in people, and the FDA status from the labels our status pages read (a dash where they hold no record).

CompoundIn peopleAnimals or cellsLargest in peopleFDA
Enclomiphene6066Not approved
HCG406,999Approved, a use tied to it
Clomiphene4046Approved for other uses
FOXO4-DRI01—Not approved

What the studies did not show

Each study page names its own limits. These are the questions still open, in the study pages’ words.

This page is a reading of published studies, not medical advice. A diagnosis, and what to do about it, is a conversation with a clinician.

Questions

Which peptides have been studied for low testosterone (hypogonadism)?

Our 15 study pages on low testosterone (hypogonadism) are filed under 4 compounds, with this many each: Enclomiphene 6, HCG 4, Clomiphene 4 and FOXO4-DRI 1. Enclomiphene has the most.

Have any been tested in people with low testosterone (hypogonadism)?

Yes: 14 of the 15 were in people, 9 of them meta-analyses or randomized trials (Enclomiphene, HCG and Clomiphene). The largest enrolled 6,999 people: “HCG with TRT lowered LH and FSH while testosterone rose in men” (2026).

Is any peptide FDA-approved for low testosterone (hypogonadism)?

Yes, with a use tied to low testosterone (hypogonadism) on their FDA labels: HCG as Chorionic Gonadotropin, Novarel and Pregnyl. 3 other compounds here with an FDA record have no use tied to it.

How large were the studies in people on low testosterone (hypogonadism)?

Of the 14 in people, 7 give their size on our pages: 1 had 1,000 people or more and 6 had fewer than 100. The largest, an observational study from 2026, enrolled 6,999.

What did the animal and cell studies on low testosterone (hypogonadism) use?

1 animal study (mice), filed under FOXO4-DRI. A result in animals or cells shows what to test next, not what happens in a person.

What is the newest study on low testosterone (hypogonadism) here?

Of our study pages on low testosterone (hypogonadism), the newest is “HCG with TRT lowered LH and FSH while testosterone rose in men”, an observational study in people published in 2026.

How this page was built

A study page is listed here only where we read its question, design and finding and the study was about this condition: its subjects had the condition, or were an animal or cell model of it, and the study gave them the compound. A study that only mentions the condition is not listed.

Studies are grouped by the compound each is filed under and ordered by design: meta-analyses and randomized trials in people first, then other studies in people, then animals, then cells, and within a group by size and then by year. The FDA status comes from the labels our legal-status and brand pages read.

Track it in the app

PepVault for iPhone

Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo